share_log

Moderna | 4: Statement of changes in beneficial ownership of securities-Officer Mock James M

Moderna | 4：持股變動聲明-高管 Mock James M

SEC announcement ·  03/01 05:45
牛牛AI助理已提取核心訊息
Moderna, Inc. (MRNA) Chief Financial Officer, James M. Mock, executed a transaction of the company's common stock on February 27, 2024. Following the reported transaction, Mock holds a total of 3,632 shares of Moderna directly. The nature of the transaction and the number of shares involved were not disclosed, nor was the transaction price. However, the total value of shares held by Mock after the action is also not specified.
Moderna, Inc. (MRNA) Chief Financial Officer, James M. Mock, executed a transaction of the company's common stock on February 27, 2024. Following the reported transaction, Mock holds a total of 3,632 shares of Moderna directly. The nature of the transaction and the number of shares involved were not disclosed, nor was the transaction price. However, the total value of shares held by Mock after the action is also not specified.
Moderna, Inc.（MRNA）首席財務官詹姆斯·莫克於2024年2月27日執行了該公司普通股的交易。在報告的交易之後，Mock直接持有Moderna總共3,632股股份。交易的性質和所涉及的股票數量沒有披露，交易價格也沒有披露。但是，也沒有具體說明Mock在行動後持有的股票的總價值。
Moderna, Inc.（MRNA）首席財務官詹姆斯·莫克於2024年2月27日執行了該公司普通股的交易。在報告的交易之後，Mock直接持有Moderna總共3,632股股份。交易的性質和所涉及的股票數量沒有披露，交易價格也沒有披露。但是，也沒有具體說明Mock在行動後持有的股票的總價值。
有用
沒用

該公告為獨立文件：

獨立文件1  查看翻譯

譯文內容由第三人軟體翻譯。


牛牛AI助手部分由第三方人工智慧模型基於資訊內容自動產生，只对除中国内地以外的地区提供。


以上內容僅用作資訊或教育之目的，不構成與富途相關的任何投資建議。富途竭力但無法保證上述全部內容的真實性、準確性和原創性。